| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 741940 | Null | 0.00163653239752571 | 0.50097367 |
| NSC 742554 | 7H-Furo[3,2-g][1]benzopyran-7-one, 4-[[(2E)-5-[4'-[[(2E)-6,7-dihydroxy-3,7-dimethyl-2-octenyl]oxy]-5,5-dimethyl-spiro[1,3-dioxolane-2,7'-[7H]furo[3,2-g][1]benzopyran]-4-yl]-3-methyl-2-pentenyl]oxy]-, | 0.00163653239752571 | 0.16328746 |
| NSC 756188 | GSK718429A | 0.00163653239752571 | 0.46275683 |
| NSC 760476 | 5,6,7,8-tetrafluoronaphtho[2,3-c][1,2,5]thiadiazole-4,9-dione | 0.00163653239752571 | 0.23545039 |
| NSC 87221 | Actinomycin D, 2A-D-alloisoleucine- (9CI) | 0.00163653239752571 | 0.2149555 |
| NSC 98904 | Thiazolo[3,2-f]phenanthridinium, 3-phenyl- perchlorate | 0.00163653239752571 | 0.20758412 |
| NSC 129794 | Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) | 0.00163653239752573 | 0.34343948 |
| NSC 13151 | Null | 0.00163653239752573 | 0.53298837 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.00163653239752573 | 0.48570655 |
| NSC 372155 | 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- | 0.00163653239752573 | 0.057115789 |